Cogent Biosciences, Inc. (COGT) vs Definium Therapeutics, Inc. (DFTX)
A side-by-side comparison of Cogent Biosciences, Inc. and Definium Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
COGT
Cogent Biosciences, Inc.
$29.80HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
DFTX
Definium Therapeutics, Inc.
$34.80HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
Total return — COGT vs DFTX
growth of $100 · dividends reinvested · last 9yCOGT -30.5% (-4.0%/yr)DFTX +1510.2% (+36.2%/yr)DFTX compounded faster over this window
Log scale — wide-divergence pair
COGT DFTX
COGT vs DFTX: by the numbers
- •COGT is the larger company ($5.09B vs $4.62B market cap).
Metrics side by side
Valuation
| Metric | COGT | DFTX |
|---|---|---|
| P/B ratio | 10.89 | 5.03 |
Profitability
| Metric | COGT | DFTX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -70.85% | -38.51% |
| ROIC | -50.09% | -23.81% |
Growth (annualized)
| Metric | COGT | DFTX |
|---|---|---|
| Total return CAGR (5Y) | 28.51% | 1.43% |
Frequently asked
- How have COGT and DFTX total returns compared?
- Over the past 5 years, COGT delivered 28.51% and DFTX delivered 1.43% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.